Request for Single Patient IND for Compassionate/Emergency Use of Tocilizumab

Part of paid clinical trials in Oklahoma City, Oklahoma.

Sponsor
University of Oklahoma
Study ID
NCT00862758
Status
No Longer Available

Conditions

Eligibility Criteria

Sex
MALE
Age
11 Years - 12 Years
Healthy Volunteers
Not accepted

Interventions

  • Tocilizumab — DRUG
    8 mg/kg would be administered IV every 2 weeks for six weeks.

Study Details

Application for Compassionate Use of Tocilizumab in a Boy with Severe Polyarticular Juvenile Idiopathic Arthritis (JIA) Unresponsive to All Licensed Medications.

Key Dates

Start date
Feb 28, 2009
Status verified
Dec 2013
Primary completion
Oct 31, 2010
Completion
Oct 31, 2010

Locations (1)

FacilityCityStateZIPSite coordinators
University of Oklahoma Health Sciences CenterOklahoma CityOklahoma73104-

Find similar trials in Oklahoma City, OK

By research site
University of Oklahoma Health Sciences Center· Oklahoma City, OK

Related Studies